# NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma

> **NCT06972693** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 323 (actual)

## Conditions studied

- Ovarian Carcinoma
- Fallopian Tube Carcinoma
- Primary Peritoneal Carcinoma

## Interventions

- **GENETIC:** BRCA testing

## Key facts

- **NCT ID:** NCT06972693
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-06-12
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06972693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06972693, "NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06972693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*